Table 2.
Correlations with the TAPSE/PASP ratio in patients with COPD without pulmonary hypertension.
Parameter | Pearson R | P-value | Spearman rho | P-value |
---|---|---|---|---|
Age, years | −0.316 | <0.001 | −0.297 | <0.001 |
CAT score | −0.141 | 0.06 | −0.133 | 0.08 |
Pack years | −0.153 | 0.03 | −0.089 | 0.2 |
6MWD, m | 0.314 | 0.007 | 0.326 | 0.005 |
FEV1, % pred | 0.310 | <0.001 | 0.340 | <0.001 |
FEV1/VC max | 0.235 | <0.001 | 0.277 | <0.001 |
TLC, % pred | −0.123 | 0.07 | −0.092 | 0.2 |
VC, % pred | 0.281 | <0.001 | 0.274 | <0.001 |
FVC, % pred | 0.246 | <0.001 | 0.254 | <0.001 |
DLCO, % pred | 0.423 | <0.001 | 0.414 | <0.001 |
6MWD, 6-min walk distance; % pred, % predicted; CAT, COPD Assessment Test; DLCO, lung diffusing capacity for carbon monoxide; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; max, maximum; PASP, pulmonary artery systolic pressure; TAPSE, tricuspid annular plane systolic excursion; TLC, total lung capacity; VC, vital capacity.